Active substance
Results for the substance glofitamab
2 results
About this active substance
Glofitamab is a medication used in the treatment of certain types of non-Hodgkin lymphoma, particularly diffuse large B-cell lymphoma. It is a monoclonal antibody that targets specific proteins on the surface of cancer cells.
This medication works by activating the body's immune system to recognize and destroy cancer cells. It is administered intravenously under strict medical supervision.
Glofitamab may cause side effects, including fever, fatigue, nausea, or injection site reactions. In rare cases, severe reactions such as cytokine release syndrome may occur.
It is essential to follow your doctor's instructions and report any side effects or unusual symptoms during treatment. Regular monitoring is necessary to ensure the safety and effectiveness of the therapy.
This medication works by activating the body's immune system to recognize and destroy cancer cells. It is administered intravenously under strict medical supervision.
Glofitamab may cause side effects, including fever, fatigue, nausea, or injection site reactions. In rare cases, severe reactions such as cytokine release syndrome may occur.
It is essential to follow your doctor's instructions and report any side effects or unusual symptoms during treatment. Regular monitoring is necessary to ensure the safety and effectiveness of the therapy.